JP2019515878A5 - - Google Patents
Info
- Publication number
- JP2019515878A5 JP2019515878A5 JP2018548895A JP2018548895A JP2019515878A5 JP 2019515878 A5 JP2019515878 A5 JP 2019515878A5 JP 2018548895 A JP2018548895 A JP 2018548895A JP 2018548895 A JP2018548895 A JP 2018548895A JP 2019515878 A5 JP2019515878 A5 JP 2019515878A5
- Authority
- JP
- Japan
- Prior art keywords
- groups
- substituted
- unsubstituted
- acid
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610149958.6 | 2016-03-16 | ||
| CN201610149958.6A CN107200706A (zh) | 2016-03-16 | 2016-03-16 | 一类氟取代的环丙胺类化合物及其制备方法、药物组合物和用途 |
| PCT/CN2017/076967 WO2017157322A1 (zh) | 2016-03-16 | 2017-03-16 | 一类氟取代的环丙胺类化合物及其制备方法、药物组合物和用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019515878A JP2019515878A (ja) | 2019-06-13 |
| JP2019515878A5 true JP2019515878A5 (cg-RX-API-DMAC7.html) | 2022-03-09 |
| JP7605579B2 JP7605579B2 (ja) | 2024-12-24 |
Family
ID=59850098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018548895A Active JP7605579B2 (ja) | 2016-03-16 | 2017-03-16 | フッ素置換シクロプロピルアミン系化合物並びにその製造方法、薬物組成物及び使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10836743B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3431471A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7605579B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102196050B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN107200706A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3021608C (cg-RX-API-DMAC7.html) |
| RU (1) | RU2746323C9 (cg-RX-API-DMAC7.html) |
| SG (1) | SG11201808017PA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017157322A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017263361B2 (en) * | 2016-05-09 | 2021-08-05 | Jubilant Epicore LLC | Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors |
| CN107459476B (zh) * | 2016-06-03 | 2022-06-24 | 中国科学院上海药物研究所 | 反吲哚啉环丙胺类化合物及其制备方法、药物组合物和用途 |
| US20190256930A1 (en) | 2016-11-03 | 2019-08-22 | Oryzon Genomics, S.A. | Biomarkers for determining responsiveness to lsd1 inhibitors |
| WO2018137644A1 (zh) * | 2017-01-24 | 2018-08-02 | 南京明德新药研发股份有限公司 | Lsd1抑制剂及其制备方法和应用 |
| AU2018309372B2 (en) | 2017-08-03 | 2024-08-15 | Oryzon Genomics, S.A. | Methods of treating behavior alterations |
| CN109321940A (zh) * | 2018-11-30 | 2019-02-12 | 西南大学 | 一种酰胺的电化学氧化合成方法及其应用 |
| SI3941466T1 (sl) | 2019-03-20 | 2026-04-30 | Oryzon Genomics, S.A. | Vafidemstat za zdravljenje neagresivnih simptomov mejne osebnostne motnje |
| HRP20251471T1 (hr) | 2019-03-20 | 2026-01-02 | Oryzon Genomics, S.A. | Postupci liječenja poremećaja hiperaktivnosti s deficitom pažnje korištenjem inhibitora kdm1a kao što je spoj vafidemstat |
| CN114341366A (zh) | 2019-07-05 | 2022-04-12 | 奥莱松基因组股份有限公司 | 用于使用kdm1a抑制剂个体化治疗小细胞肺癌的生物标志物和方法 |
| CN112939846B (zh) * | 2019-11-26 | 2023-12-26 | 中国科学院上海药物研究所 | 一种乙酰胆碱酯酶抑制剂的晶型及其制备方法和应用 |
| CA3231846A1 (en) | 2021-04-08 | 2022-10-13 | Tamara Maes | Combinations of lsd1 inhibitors for treating myeloid cancers |
| US20250275969A1 (en) | 2022-05-09 | 2025-09-04 | Oryzon Genomics, S.A. | Methods of treating malignant peripheral nerve sheath tumor (mpnst) using lsd1 inhibitors |
| US20250295660A1 (en) | 2022-05-09 | 2025-09-25 | Oryzon Genomics, S.A. | Methods of treating nf1-mutant tumors using lsd1 inhibitors |
| US20260151399A1 (en) | 2022-11-24 | 2026-06-04 | Oryzon Genomics, S.A. | Combinations of lsd1 inhibitors and menin inhibitors for treating cancer |
| CN118239883A (zh) * | 2022-12-22 | 2024-06-25 | 江苏联环药业股份有限公司 | 一类赖氨酸特异性脱甲基酶1(lsd1)抑制剂的制备方法 |
| CN118787751A (zh) * | 2023-04-12 | 2024-10-18 | 中国科学院上海药物研究所 | Lsd1抑制剂与药物联用治疗癌症的用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS55348B1 (sr) | 2010-04-19 | 2017-03-31 | Oryzon Gnomics S A | Inhibitori lizin specifične demetilaze-1 i njihova upotreba |
| DK2598482T3 (en) * | 2010-07-29 | 2018-06-14 | Oryzon Genomics Sa | ARYLCYCLOPROPYLAMINE-BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR MEDICAL USE |
| MX347913B (es) * | 2011-03-25 | 2017-05-17 | Glaxosmithkline Intellectual Property (No 2) Ltd | Ciclopropilaminas como inhibidores de desmetilasa 1 especifica de lisina. |
| AU2012324803B9 (en) | 2011-10-20 | 2017-08-24 | Oryzon Genomics, S.A. | (hetero)aryl cyclopropylamine compounds as LSD1 inhibitors |
| US9469597B2 (en) | 2011-10-20 | 2016-10-18 | Oryzon Genomics S.A. | (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors |
| US9527835B2 (en) * | 2014-02-13 | 2016-12-27 | Incyte Corporation | Cyclopropylamines as LSD1 inhibitors |
| EP3392244A1 (en) * | 2014-02-13 | 2018-10-24 | Incyte Corporation | Cyclopropylamines as lsd1 inhibitors |
| LT3105218T (lt) | 2014-02-13 | 2019-12-10 | Incyte Corp | Ciklopropilaminai kaip lsd1 inhibitoriai |
| WO2015123424A1 (en) | 2014-02-13 | 2015-08-20 | Incyte Corporation | Cyclopropylamines as lsd1 inhibitors |
-
2016
- 2016-03-16 CN CN201610149958.6A patent/CN107200706A/zh active Pending
-
2017
- 2017-03-16 KR KR1020187029900A patent/KR102196050B1/ko active Active
- 2017-03-16 SG SG11201808017PA patent/SG11201808017PA/en unknown
- 2017-03-16 US US16/085,311 patent/US10836743B2/en active Active
- 2017-03-16 EP EP17765864.8A patent/EP3431471A4/en active Pending
- 2017-03-16 CN CN201780017669.3A patent/CN108779096B/zh active Active
- 2017-03-16 CA CA3021608A patent/CA3021608C/en active Active
- 2017-03-16 RU RU2018136336A patent/RU2746323C9/ru active
- 2017-03-16 WO PCT/CN2017/076967 patent/WO2017157322A1/zh not_active Ceased
- 2017-03-16 JP JP2018548895A patent/JP7605579B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2018136336A (ru) | Фторированное соединение циклопропиламина, способ получения, фармацевтическая композиция и ее использование | |
| RU2015148006A (ru) | Дейтерированные нуклеозидные пролекарства, применимые для лечения hcv | |
| RU2011124304A (ru) | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе | |
| HRP20201985T1 (hr) | Piridonski spoj kao c-met inhibitor | |
| ECSP034475A (es) | Derivados de 4-fenil-piridin como antagonistas del receptor de neuroquinina-1 | |
| RU2009143926A (ru) | Производные пиридина, замещенные гетероциклическим циклом и фосфоноаминогруппой, и содержащее их противогрибковое средство | |
| RU2014145819A (ru) | Бициклическое соединение | |
| RU2010126105A (ru) | Производные пиридина, замещенные гетероциклическим кольцом и фосфоноксиметильной группой, и содержащие их противогрибковые средства | |
| RU2011119990A (ru) | Циклоалкиламины в качестве ингибиторов повторного поглощения моноамина | |
| AR067896A1 (es) | Procedimiento para sintetizar compuestos utiles para tratar hepatitis c | |
| EA201391324A1 (ru) | Бис(фторалкил)-1,4-бензодиазепиноновые соединения | |
| EA200701640A1 (ru) | Новые соединения с терапевтическим эффектом | |
| JP2007538092A5 (cg-RX-API-DMAC7.html) | ||
| AR045738A1 (es) | Derivados de bencimidazol n3 alquilados como inhibidores de mek | |
| JP2009511490A5 (cg-RX-API-DMAC7.html) | ||
| AR072490A1 (es) | 1,2,5- oxadiazoles como inhibidores de indolamina 2,3 dioxigenasa | |
| AR112789A2 (es) | COMPUESTOS INHIBIDORES DE DOPAMINA-b-HIDROXILASA | |
| RU2012109554A (ru) | Лиганды сигма-рецепторов для предупреждения или лечения боли, вызванной химиотерапией | |
| JP2020063289A5 (cg-RX-API-DMAC7.html) | ||
| RU2005133994A (ru) | Оксимные производные и их применение в качестве фармацевтически активных агентов | |
| RU2013125326A (ru) | Гетероциклические соединения в качестве зондов для визуализации tau-патологии | |
| EA201071012A1 (ru) | Производные азетидинов, способ их получения и применение их в терапии | |
| AR121674A1 (es) | Amidas heterocíclicas como inhibidoras del receptor de tirosina quinasa de tipo iii | |
| EA200801536A1 (ru) | Новые тиенопирсульфоновые производные | |
| JP2022512919A5 (cg-RX-API-DMAC7.html) |